New study tracks ovarian cancer care in real life
NCT ID NCT04830709
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study follows 750 women with advanced ovarian cancer in Germany to see how they are treated in real-world settings. It focuses on the use of PARP inhibitor maintenance therapy after chemotherapy and how it affects outcomes and quality of life. The goal is to learn what works best for patients and doctors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide insights into how well current treatments work in everyday practice and help improve care for ovarian cancer patients.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may be influenced by differences in patient care across hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
Böblingen, Germany, 71032, Germany
-
Research Site
Göttingen, Germany, 37075, Germany
-
Research Site
Nürtingen, Germany, 72622, Germany
-
Research Site
Osnabrück, Germany, 49076, Germany
-
Research Site
Rotenburg (Wümme), Germany, 27356, Germany
-
Research Site
Aachen, 52074, Germany
-
Research Site
Amberg, 92224, Germany
-
Research Site
Aschaffenburg, 63739, Germany
-
Research Site
Augsburg, 86156, Germany
-
Research Site
Bayreuth, 95445, Germany
-
Research Site
Berlin, 10367, Germany
-
Research Site
Berlin, 10967, Germany
-
Research Site
Berlin, 12101, Germany
-
Research Site
Berlin, 12559, Germany
-
Research Site
Berlin, 13187, Germany
-
Research Site
Berlin, 13353, Germany
-
Research Site
Berlin, 13509, Germany
-
Research Site
Berlin, 14163, Germany
-
Research Site
Berlin, 14169, Germany
-
Research Site
Bielefeld, 33604, Germany
-
Research Site
Bielefeld, 33611, Germany
-
Research Site
Bochum, 44791, Germany
-
Research Site
Bonn, 53113, Germany
-
Research Site
Borna, 4552, Germany
-
Research Site
Bottrop, 46236, Germany
-
Research Site
Brandenburg an der Havel, 14770, Germany
-
Research Site
Bremen, 28205, Germany
-
Research Site
Coburg, 96450, Germany
-
Research Site
Cologne, 50931, Germany
-
Research Site
Cologne, 50935, Germany
-
Research Site
Dessau, 6947, Germany
-
Research Site
Dortmund, 44137, Germany
-
Research Site
Dresden, 1307, Germany
-
Research Site
Düsseldorf, 40489, Germany
-
Research Site
Eggenfelden, 84307, Germany
-
Research Site
Erfurt, 99084, Germany
-
Research Site
Fürth, 90766, Germany
-
Research Site
Gelnhausen, 63571, Germany
-
Research Site
Gera, 7548, Germany
-
Research Site
Halle, 6110, Germany
-
Research Site
Hamburg, 20246, Germany
-
Research Site
Hamburg, 22307, Germany
-
Research Site
Hamburg, 22457, Germany
-
Research Site
Hanau, 63450, Germany
-
Research Site
Heilbronn, 74078, Germany
-
Research Site
Hildesheim, 31134, Germany
-
Research Site
Homburg, 66421, Germany
-
Research Site
Itzehoe, 25524, Germany
-
Research Site
Jena, 7747, Germany
-
Research Site
Kiel, 24116, Germany
-
Research Site
Krefeld, 47805, Germany
-
Research Site
Leipzig, 4103, Germany
-
Research Site
Limburg, 65549, Germany
-
Research Site
Lübeck, 23562, Germany
-
Research Site
Magdeburg, 39108, Germany
-
Research Site
Magdeburg, 39130, Germany
-
Research Site
Mainz, 55131, Germany
-
Research Site
Mönchengladbach, 41061, Germany
-
Research Site
Mutlangen, 73557, Germany
-
Research Site
München, 80638, Germany
-
Research Site
Münster, 48145, Germany
-
Research Site
Nuremberg, 90419, Germany
-
Research Site
Offenburg, 77654, Germany
-
Research Site
Pforzheim, 75179, Germany
-
Research Site
Plauen, 08525, Germany
-
Research Site
Potsdam, 14467, Germany
-
Research Site
Recklinghausen, 45659, Germany
-
Research Site
Regensburg, 93053, Germany
-
Research Site
Rheine, 48431, Germany
-
Research Site
Rosenheim, 83022, Germany
-
Research Site
Rostock, 18059, Germany
-
Research Site
Saarlouis, 66740, Germany
-
Research Site
Siegen, 57072, Germany
-
Research Site
Singen, 78224, Germany
-
Research Site
Solingen, 42653, Germany
-
Research Site
Stendal, 39576, Germany
-
Research Site
Stralsund, 18439, Germany
-
Research Site
Stuttgart, 70174, Germany
-
Research Site
Stuttgart, 70199, Germany
-
Research Site
Torgau, 4860, Germany
-
Research Site
Traunstein, 83278, Germany
-
Research Site
Ulm, 89075, Germany
-
Research Site
Villingen-Schwenningen, 78052, Germany
-
Research Site
Wiesbaden, 65199, Germany
-
Research Site
Winnenden, 71364, Germany
-
Research Site
Witten, 58452, Germany
-
Research Site
Wolfsburg, 38440, Germany
-
Research Site
Worms, 67550, Germany
-
Research Site
Wuppertal, 42283, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a new PET tracer light up hidden cancers?
- A Two-for-One surgery: could tube removal during Weight-Loss surgery slash ovarian cancer risk?
- Can AI spot ovarian cancer on CT scans before It's too late?
- Can Lab-Grown tumors unlock the secrets of ovarian cancer resistance?
- Can a smart drug home in on Hard-to-Treat cancers?